Purpose: Hand-held vital microscopes (HVMs) were introduced to observe sublingual microcirculatory alterations at the bedside in different shock states in critically ill patients. This consensus aims to provide clinicians with guidelines for practical use and interpretation of the sublingual microcirculation. Furthermore, it aims to promote the integration of routine application of HVM microcirculatory monitoring in conventional hemodynamic monitoring of systemic hemodynamic variables.
Introduction
A large body of evidence on the presence of microcirculatory alterations in critically ill patients has come to light since the clinical introduction of hand-held vital microscopes (HVMs) in the late 1990s. This evidence has led to the need to formulate an update of a consensus on sublingual microcirculatory imaging as applied at the bedside. The first applications of HVM were accomplished by the introduction of the first generation of HVM called orthogonal polarization spectral (OPS) imaging during neurosurgery [1, 2] . Consequently, this led the way to the measurement of microcirculatory alterations in critically ill patients at the bedside where De Backer and co-workers reported that persistent microcirculatory alterations in patients with septic shock were associated with increased mortality, independent of alterations of the systemic macrocirculation [3] . Spronk and co-workers demonstrated that nitroglycerine therapy following pressure-guided resuscitation improved microcirculatory flow in patients with septic shock [4] . Soon after, an increasing number of manuscripts using HVM were published, the majority of which concerned critically ill patients. From the results it became clear that microcirculatory alterations were significantly correlated with the progress of human sepsis and predictive of organ failure and mortality [5] [6] [7] [8] [9] [10] . Although most microcirculatory measurements using HVM were carried out in the sublingual area, several investigations of the microcirculation were carried out directly on organ surfaces during surgery [2, [11] [12] [13] [14] [15] . Indeed, sublingual microcirculatory alterations have been identified using HVM in a wide range of disease states other than sepsis and shock [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] and in different age groups including critically ill newborns [27] . In 2009, an international multicenter observational prevalence study in intensive care patients involving 36 ICUs worldwide enrolling 501 patients identified microcirculatory alterations (microvascular flow index, MFI < 2.6) in combination with tachycardia (heart rate > 90) as an independent risk factor for increased hospital mortality [28] . Various studies have been undertaken to define normal values in adults, newborns, and neonates [29] [30] [31] [32] [33] , as well as in healthy individuals under extreme environmental conditions [34, 35] . In studies where systemic hemodynamic monitoring was being applied, it became increasingly clear that microcirculatory alterations can occur independently from systemic hemodynamic alterations and that these microcirculatory alterations were independently associated with adverse clinical outcome [6] [7] [8] . However, the practical application of microcirculatory measurement using HVM and the interpretation of the images of these measurements remain challenging.
Technical developments of HVM helped in making the measurement of the microcirculation increasingly feasible. The technical issue that had to be overcome in the application of HVM for studying the microcirculation on organ surfaces was the need for an optical system to be developed, where illumination and observation of the microcirculation beneath the surface of an organ are accomplished through the same optical pathway embedded in a light guide with a magnification lens attached to its end.
The first generation of such HVM devices which solved this problem was based on orthogonally polarized spectral (OPS) imaging [1, 36] , where an externally filtered light source illuminated the organ surface with linearly polarized light, and reflected light was blocked by an orthogonally polarized analyzer. Although these firstgeneration HVM devices pioneered the initial studies, they are no longer commercially available. The second generation was based on sidestream dark-field (SDF) imaging, whereby illumination was achieved by surrounding the tip of the light guide with light-emitting diodes creating dark-field illumination [37] . Recently, a third-generation device was introduced which is based on an alternative mode of dark-field microscopy called incident dark-field (IDF) imaging [38] with improved optical resolution which gave better image quality and allowed for the visualization of more capillaries than previous-generation devices [39] [40] [41] [42] . The last two techniques are currently commercially available. Massey and Shapiro wrote an excellent comprehensive review of the technical aspects of HVM [43] . Table 1 summarizes the different technical properties of the currently available HVM devices obtained from this publication.
An important reason to evaluate the functional state of the microcirculation in conditions of shock and resuscitation is to verify the expectation that correction of systemic hemodynamic variables results in a parallel improvement in tissue perfusion, a condition referred to as hemodynamic coherence [44] . However, uncertainty remains when correction of systemic hemodynamic variables has been achieved, but downstream variables used as surrogates for tissue hypoperfusion, such as lactate, mottling skin, oliguria, and cold extremities, remain unaltered and abnormal. This can occur as a consequence of the nature of the disease or due to an ineffective therapy such fluids [45, 46] or vasopressors not being effective in improving the microcirculation [47] [48] [49] . Such a loss of coherence between the macro-and microcirculation has been described in several clinical and experimental studies [8, 23, 44, [48] [49] [50] [51] [52] and has been found to be an independent predictor of adverse outcome and organ dysfunction [6] [7] [8] [9] [10] . Its manifestation, however, is a dynamic process depending on the interactions between disease, therapy, and time. Figure 1 summarizes four conditions in which this loss of hemodynamic coherence occurs and microcirculatory alterations persist despite optimization of systemic hemodynamic variables [44] . Monitoring the microcirculation during resuscitation procedures can then verify whether they have been effective in restoring tissue perfusion to some minimal value, which is the ultimate expected result of resuscitation procedures. Observation of the type of microcirculatory alterations can unveil information about the mechanisms causing shock and help to determine an appropriate therapeutic response [46] .
A consensus was published in 2007 by a group of experts to discuss the various technical, physiological, and clinical aspects of microcirculatory monitoring. The resulting consensus paper described the conditions that needed to be met for image acquisition and consolidated the various scoring methodologies being developed at the time [53] . These methodologies related to the description of functional variables obtained from analysis of the HVM-derived microcirculatory images. Some 10 years later more than 600 articles about clinical and experimental investigations using HVM have been published. Together with current developments in the technology of HVM by introduction of a third-generation computercontrolled image sensor-based HVM with improved optics, it became clear that the definitions in the previous consensus had to be adapted and that it was necessary to organize an updated second consensus on the state of the art of HVM and its application in intensive care medicine. Table 2 summarizes the main differences between the previous Critical Care 2007 consensus paper and the current Intensive Care Medicine 2018 consensus article, which comprises image quality, analysis, and future perspectives.
Methods
This paper reflects the current state of the art of monitoring of the (sublingual) microcirculation and describes the consensus reached on the requirements for ensuring good quality measurements, as well as the analysis for obtaining variables reflecting the functional status of the microcirculation by the experts listed as authors. Since HVM measurements are predominantly performed in the sublingual area, we will restrict ourselves to the methodology in this particular vascular bed. The present paper was endorsed by the Executive Committee of the European Society of Intensive Care Medicine (ESICM) as an expert opinion guideline for microcirculation monitoring in 2017. The intended format of this paper has been taken from previous expert opinion papers, e.g., the guideline on circulatory shock and hemodynamic monitoring [54] and the position paper on hemodynamic monitoring [55] . We addressed five questions regarding the methodology and interpretation of microcirculatory alterations using HVM: (1) What has been the development of the technology since the last consensus of 2007? To arrive at this consensus we organized three international meetings in accordance with the Delphi method, where an agreement of more than 80% of the authors of the present paper on the statements (definitions, requirements, and recommendations) listed in the tables was considered as being a consensus [54] . During the first meeting (Amsterdam, November 20th 2015) all participants identified the issues including the various aspects of the technology, physiology, measurements, and clinical utility of the current consensus document. During the second meeting (Brussels March 16th 2016) these topics were structured into three categories: image acquisition and quality, image analysis, and future perspectives. In the wake of this meeting a document was composed that summarized the process in a body of statements. All participants were offered the opportunity to respond to the content and formulation of these statement by e-mail. During the final session (Brussels, March 22nd 2017) the aim was to compose the present paper as a consensus document. These three meetings were then considered to be sufficient to meet the Delphi requirements. The body of statements was formulated in its final form and accepted by all participants. The Executive Committee of the ESICM endorsed this consensus by the Cardiovascular Dynamics Section as an update of a previous consensus published in 2007 [53] . We classified the consensus statements as definitions (fact or meaning), requirements (a prerequisite or minimum for sufficient quality), and recommendations (advice that enhances quality).
Results

Quality assessment of acquired HVM microcirculatory images
A prerequisite for assessing the function of the microcirculation using HVM imaging is to ensure that artifact-free measurements are made. This is a requirement of any monitoring device measuring physiological variables, each having its own specific sensitivity to the introduction of artifacts. That is why the use of HVM measurements requires skill and training (Requirement #5, Table 3 ) similar to other clinical monitoring/diagnostic techniques, such as echocardiography [43] . Although not discussed in the consensus meetings as to the precise Hyperdynamic flow Recommendations with respect to hyperdynamic flow were not included We recommend restricting indices of hyperdynamic red blood cell velocity to specific pathophysiologic situations and to limit assessment to space-timeframe-derived exact red blood cell velocity content of a training schedule, it should consist of theoretical and practical knowledge about making and analyzing sublingual microcirculatory imaging as covered in the present consensus. Artifacts can be classified as pressure artifacts, illumination, focus, content, and focus artifacts (uneven focus) (Fig. 2) . The main quality requirement for an acceptable HVM measurement is that single red blood cells can be visualized in the capillaries (Requirement #2, Table 3 ). For this to be accomplished, images should be well focused and obtained free of pressure artifacts (Requirement #3, Table 3 ). Applying excessive pressure to the tissue surface is the most common of these artifacts and can lead to the incorrect diagnosis of a low flow state. Use of HVM can cause such artifacts because the tip of the probe has to make physical contact with the tissue surface. As was already recognized in the first consensus meeting, pressure artifacts constitute the main technical challenge in performing HVM measurements. The presence of such artifacts can be recognized as flow being impeded in larger venules (> 20 µm), since it is agreed that restricted flow in these large vessels occurs mainly because of excessive pressure being applied. Slight release of the pressure, and noting the restoration of flow, confirms that excessive pressure had been applied during the measurement. Other artifacts that must be avoided consist of content, focus, and illumination, examples of which can be seen in Fig. 2 . As a result of the heterogeneity of the microcirculation in the sublingual area, it is recommended to measure in multiple sites, as well as to average the values found during analysis of the different areas. An alteration from the previous recommendation is to take a minimum of three sublingual areas (previous recommendation was five) (Recommendation #6, Table 3 ). This is needed because the current HVM generation has a significantly larger field of view. Additionally, the possibility to make single-spot measurements for extended periods of time has been added in order to observe changes in single vessels during a therapeutic Image acquisition and quality statements Definitions 1. Microvessels are defined as vessels with a diameter < 20 µm containing arterioles, capillaries, and venules. Capillaries are defined as vessels < 10 µm in diameter where a single file of red blood cells can be observed. The main characteristics of venules include that they are vessels that are collecting flow from other vessels and have more RBC filling in the lumen than single RBCs as seen in capillaries Requirements 2. These should be high-quality images where RBC can be clearly seen in the capillaries 3. Images should be evenly illuminated, well focused, possess good contrast, and be free of pressure artifacts. Artifacts are defined as absence of flow in vessels > 20 µm that returns after release of pressure. An additional characteristic of artifacts is alternating bi/directional flow. A quality score should be applied to describe the quality of recording (according to Massey [58] ). The quality score should be reported in the article 4. Image sequences should be composed of motion-free images of at least 4 s (100 frames is the minimum needed to generate space-time frames) but ideally should last 20 s in order not to miss intermittent flow. The movement of artifact-free images can be obtained either by hand or by software correction 5. Proper training is required to obtain images of acceptable quality and to perform adequate image analysis. The training and/or experience undergone should be stated when reporting results
Recommendations
6. In the previous consensus, a minimum of 3-5 sites was agreed upon; in this new consensus, we add the possibility of using a single-spot measurement during a procedure for evaluating the response of single vessels 7. Measurements of hyperdynamic flow should not be done routinely but restricted to pathophysiological disease states in which hyperdynamic flow is anticipated. Hyperdynamic flow is defined as a red blood cell velocity above normal flow in healthy volunteers under resting conditions. Measurements of hyperdynamic flow should be done quantitatively by space-time frames and not be added to existing semi-quantitative scores. Measurements of hyperdynamic flow are physically restricted by the frame rate, according to the following equation:
where L is the vessel length in µm, f the frame rate (25 or 30 Hz), and 3 is the number of video frames used for the calculation 8. Unless for specialized application images (specialized locations such as organ surfaces during surgery, cutaneous microcirculation), sublingual measurements should include a mix of capillaries and venules and, if possible, arterioles. Vessel loops should be avoided as they are considered to be from a different anatomical area in the mouth 9. Differences in normal values for vessel density (TVD and PVD) between various optical systems may be up to 30%, depending on resolution, field size, and focus, and therefore are not interchangeable in between. These characteristics do not influence variables of red blood cell velocity 10. In the previous recommendation, the use of 5× objectives with OPS and SDF devices was advised for human sublingual microcirculation and a 10× objectives for small animals. On the basis of the unavailability of 10× objectives and lack of literature supporting this previous recommendation, we abandon this advice and recommend using higher-magnification objectives 11. In the previous consensus, it was stated that "In larger venules, rolling and adherent leukocytes can be observed, but this requires higher magnification and different analytical methods". However, with the current technology, leukocytes can be readily seen in the venules, and higher magnification is not required intervention (Recommendation #6, Table 3 ) [56, 57] . The minimum advised recording is 4 s in the current guidelines (Recommendation #6, Table 3 ) [43] . However, we suggest to record about 20 s as such time frames can contain extra information about microcirculatory kinetics provided a stable recording can be achieved with no movement or pressure artifacts. Care should be taken when measuring exact red blood cell velocity, especially during hyperdynamic flow, when the limitation of the sampling frequency of the capture card should be taken into account (Recommendation #7, Table 3 ). Hyperdynamic flow is a source of controversy as several investigators report its presence in critically ill patients, while other do not. Since volunteers at rest do not show such hyperdynamic flow, its presence can be interpreted as a microcirculatory alteration, although its origin and clinical meaning still have to be determined. Even though its presence can be noted, its quantification can be problematic because of limitations of the ability of the image acquisition to capture the images sufficiently rapidly to allow quantification of the velocity of hyperdynamic flow (Recommendation #7, Table 3 ). Caution is required when comparing normal values of total vessel density, because these can be influenced not only by disease states [26] and ethnicity [33] but, more importantly, by the device used. This is because the third-generation IDF devices have improved optics with which 30% more vessels can be visualized in comparison to the previous-generation devices (Recommendation #9, Table 3 ) [50, 51] . A representative mix of vessels including capillaries, venules, and possibly arterioles (Recommendation #8, Table 3 ) should be chosen for a measurement, and care should be taken to avoid too many vessel loops and venules (Fig. 2a) . In addition, focus should be adjusted so that single red blood cells in the capillaries are visualized, and the field of view should be free of artifacts such as excessive saliva or bubbles (Fig. 2 ). This consensus, in contrast to the previous consensus, did not see the urgency to develop higher-magnification devices, since the improved optics currently used are well suited to observe detailed red blood cell and leukocytes presence (Recommendations #10 and #11, Table 3 ). However, new as yet unexplored subcellular structures such as the glycocalyx or cell-tocell junctions could be observed with HVM devices with specialized optics. New in this consensus is the requirement to have an objective measure (e.g., score) for the quality of the image based on the above considerations. Such objective quality scores have been developed and used in the literature and open the way for an impartial evaluation of the quality of the image to be embedded in software as a prerequisite for automatic analysis software [58] [59] [60] . We recommend that an objective quality score, such as that described by Massey et al., should be reported as part of the methods section in each applicable scientific paper. Its reported interrater agreement (κ) on the individual components ranges between 0.71 and [58] .
Analysis and interpretation of HVM-recorded sublingual microcirculation
The main functional property of the microcirculation which needs evaluation in the context of shock and resuscitation is its capacity to perfuse the tissues with red blood cells that transport oxygen to the tissue cells.
The two main functional components of the microcirculation that describe this physiological function are the flow of red blood cells through the capillaries (convective transport of oxygen) and the density of perfused capillaries (diffusive transport of oxygen; also referred to as functional capillary density) (Definition #12, Table 4 ). Using these two physiological properties of the microcirculation, plus the microcirculatory alterations which have been observed in states of critical illness (perfusion heterogeneity, specifically in sepsis), several functional microcirculatory measures have been developed, as described in the first consensus meeting [53] . On the basis of the limitations of the technology and software at the time of the first consensus, it was decided that functional measures should be introduced, which could be determined without the need for specialized software. This requirement led to the development of grid-based scoring methods, whereby a grid is drawn on the screen, and the properties of vessels intersecting the lines of the grid can be quantified (De Backer score [53] ) and capillary flow evaluated (microvascular flow index, MFI [61] ) (Recommendation #13, Table 4 ). For the assessment of the MFI the screen is divided into four quadrants and a score between 0 and 3 reflecting the average red blood cell velocity is given per quadrant. MFI is then calculated as the mean MFI averaged over the four quadrants. Alternatively, a similar score can be generated by scoring all individual vessels on the screen and averaging their scores [7, 62] , although their precise values may deviate from the quadrant-based MFI calculations. Table 4 lists these measurements and their properties. Microcirculatory images can be analyzed by (a) realtime visual evaluation ("eyeballing"), (b) off-line manual analysis (e.g., grid-based or complete screen-based), (c) offline software-aided analysis, or (d) online automatic analysis (Definition #13, Table 4 ). Several studies have shown that real-time point-of-care (POC) assessment by visual inspection of microcirculatory properties at the bedside shows good agreement with off-line evaluation of the microcirculation afterwards (Recommendation #18, Table 4 ). These instant evaluations have been described, as used by nurses [63] , and scoring systems have been developed and validated for instant evaluation of the severity of microcirculatory dysfunction [63] [64] [65] [66] [67] .
These analysis methods are focused mainly on alterations in microcirculatory flow by MFI determination, as this value can most easily be evaluated by visual inspection of the moving microcirculatory images. The POC methods for identifying microcirculatory alterations at the bedside can form a crucial bridge to the acceptance of HVM monitoring as a routine monitor in the clinic, pending the development of reliable automatic analysis software, since they can potentially provide instant evaluation of the presence of microcirculatory alterations and potentially support clinical decisions. However, whether such POC use can make a difference to the condition of patients will have to be demonstrated in clinical intervention trials.
From these and other studies, MFI values ≤ 2.6 are generally agreed upon to identify states of microcirculatory alterations (Recommendation #23 Table 4 ). It should be emphasized however that this threshold value of 2.6 requires further validation in intervention trials with clinical outcomes. In analyzing the flow, it is not mandatory to divide the screen into quadrants, as evaluation of the complete screen also yields comparable information to identify the presence of microcirculatory alterations (Recommendation #22, Table 4 ). For a more detailed analysis and to calculate the measures listed in Table 5 , vessel detection is required. This can either be performed manually or can be accomplished by using specialized software such as automated vascular analysis (AVA), which has been developed for this purpose [68] . Although the introduction of AVA software has somewhat eased the methodology of analysis, as grids and vessels previously had to be drawn manually, its application remains time consuming and is a major limitation to the introduction of HVM into routine clinical practice. However, with the advancement of technology, several attempts have been made to develop automatic software capable of analysis for POC use [69] [70] [71] [72] [73] [74] . Regardless of how promising these developments may be, their use in the clinical evaluation of microcirculatory status has yet to be validated in clinical practice and cannot be recommended for this purpose presently.
Several measures have been developed and subsequently used in the literature to describe the functional properties of sublingual microcirculation. These measures have included variables describing convective flow of red blood cells (discussed above) and variables related to the diffusion distance of oxygen between the red blood cells and the tissue cells. The latter, quantified by the functional capillary density (FCD), includes total vessel density (TVD) and perfused vessel density (PVD). The minimum dataset required to describe the functional properties of the microcirculation as observed by HVM is listed in Table 6 . These measures were developed primarily for describing microcirculatory alterations relating to sepsis and therefore biased towards describing the microcirculation under such conditions. The alterations seen in sepsis are often characterized by a highly heterogeneous perfusion, with stopped flow capillaries next to vessels with flowing cells. To better characterize conditions of microcirculatory alteration other than those associated with sepsis, the consensus introduced a classification which describes the four most seen microcirculatory alterations previously observed in various clinical scenarios (Definition #15, Table 4 ) [75] . These classifications of microcirculatory alterations serve as a methodology to describe the different types of alterations observed by investigators. These types of alterations can occur on their own or mixed together, just as different pathogenic mechanisms can occur at the same time, especially in complex disease states such as sepsis. The types of alterations include: Type 1, complete stagnated capillaries (circulatory arrest, excessive use of vasopressors); Type 2, reduction in number of flowing capillaries (hemodilution); Type 3, stopped flow vessels are seen next to vessels with flowing cells (sepsis, hemorrhage, and hemodilution); Type 4, hyperdynamic flow within capillaries (hemodilution, sepsis). Space-time frames analysis should be applied when quantitative variation in RBC distinction needs to be made between different levels of velocities (in heart failure or during stepwise flow reduction on cardiopulmonary bypass or assist devices)
20. Previous recommendations stated that "large external monitors should be used instead of the liquid crystal display (LCD) screen of the computer". With the improved high definition (HD) screens currently available, this is no longer required 21. Heterogeneity of blood flow is a hallmark of distributive shock and thus a vital variable to determine the type of shock. Under such circumstances a coefficient of variation between a variable within different areas of interest should be provided to quantify this heterogeneity. Ideally, future software analysis should be able to provide a heterogeneity index based on the red blood cell velocity distribution in between individual vessels 22. In the previous consensus, it was stated that "Separation of the screen into quadrants (or using equidistant lines) is mandatory when analysis is done by eye. " However, several studies have demonstrated that microcirculatory alterations can be identified by "eyeballing" without the need to perform a quadrant analysis. This only is applicable to point-of-care assessment and not to quantification 23. As of now, data on the clinical relevance of microvascular alterations are predominantly expressed in PPV and MFI. Although cutoff values for a normal MFI are > 2.9, cutoff values for MFI of 2.6 are suggested as a threshold below which alterations can be considered clinically relevant 24. Clips should be de-identified and randomized before analysis to minimize bias 25. Microcirculatory measurements using intravital microscopy in adult humans are currently also applied to other locations than the sublingual area. For other regions, children-and animal-specific criteria for good measurement and analysis should be developed and validated The minimum dataset necessary for distinguishing between the various states of microcirculatory alterations is listed in Table 6 . Extensive literature has been published related to the effect of various pharmacological therapies on the microcirculation, as seen in states of shock including fluids [45, 46, [76] [77] [78] , blood [79] [80] [81] [82] , vasoactive medication [4, 47-49, 83, 84] , anesthesia [85, 86] , and mechanical support therapies such as extracorporeal membrane oxygenation (ECMO) [6, [87] [88] [89] [90] , cardiopulmonary bypass (CPB) [91] [92] [93] , and intra-aortic balloon pulsation (IABP) [94] [95] [96] . Table 7 lists which measures need to be assessed in order to demonstrate the efficacy of therapeutic interventions aimed at resuscitating the microcirculation. In addition to such evaluation of measures, intravenous fluids [77] or vasoactive challenge [83, 97] has been used to identify the microvascular reactivity and/or reserve (Table 8) .
Although qualitative evaluation has been extensively used in the literature, quantitative evaluation of microcirculatory flow is required for a more precise characterization of other types of flow alterations than those occurring in sepsis, which also allows for a more precise description of the amount of heterogeneity present than the scoring methodology currently used [10] . A practical example is a slower flow associated with heart failure, which can be readily observed but which may be inaptly described by the qualitative flow measures currently available. On the basis of the perception that simply giving numerical values to microcirculatory flow patterns insufficiently describes the complex flow patterns seen in microcirculatory images, the socalled space-time diagrams (STDs) were developed to describe quantitative red blood cell velocity profiles [98] (Fig. 3) . These STDs have been used in several HVM studies for quantitative evaluation and identification of abnormal blood flow patterns [7, 93] . The potential to create STDs is embedded in AVA [68] and can also be generated automatically using computer-controlled IDF imaging [72] .
From these considerations, it is clear that new automatic software analysis is a key requirement for the improvement of HVM. Technological advances including computer-controlled HVM, where illumination and image capturing are synchronized, will allow automatic software to be developed more readily. Within the software, quality analysis of the images, image stabilization, and quantitative recognition analysis will need to be present. Since other applications for HVM analysis of the sublingual microcirculation are being developed, such as in infants [27] and in various organs with multiple morphologies and states of disease [14-16, 99, 100] , future software must be flexible to incorporate these. This would open up the possibility to extend its use to other disease states and therapies, where monitoring the hemodynamics, cellular constituents, or morphology of the microcirculation would be relevant for understanding the underlying pathophysiology or the response to therapy (Recommendation #25, Table 4 ). 
Future developments and horizons
The next phase in the clinical development of HVM for bedside monitoring of the microcirculation is to integrate it into routine clinical practice (Recommendation #29, Table 9 ) [101] . The mention of microcirculatory monitoring in the consensus on circulatory shock and hemodynamic monitoring of the task force for the ESICM in 2014 [54] , as part of the arsenal of hemodynamic monitors which can be used for shock monitoring, indicates an acceptance that HVM has acquired a role in the cardiovascular monitoring for the critically ill. Despite the many publications and the application of microcirculatory monitoring using HVM in numerous clinical and experimental scenarios, along with the recent important technical developments that have been achieved in this field, further developments are needed prior to its integration into routine clinical practice. In this context it will be imperative to conduct trials whereby microcirculatory alterations are identified by HVM and corrected by specific interventions that lead to clinically relevant benefit for the patient (Recommendation #39, Table 9 ). The two foremost developments that are required are firstly ease of image acquisition, so that rapid artifact-free images can be obtained promptly, and secondly that the analysis of the images and classifications of the type of alterations present should be done rapidly, reliably, and automatically. Concerning this last point, it is advised that new, more physiologically based microcirculatory variables are introduced because they relate more directly to the function of the microcirculation which is to transport oxygen to the tissues. With the recent development of computer-controlled image sensor-based HVM systems and several automatic microcirculatory analysis software systems in progress, it is envisaged that physiologically based microcirculatory variables will be introduced in the near future. Analysis of these images would directly relate to the physiological function of the microcirculation, which is to transport oxygen to the tissues (Recommendation #30, Table 9 ). These measures were defined early on in intravital microscopy investigations as relating to the oxygen-transporting capacity of the microcirculation in muscle by capillary hematocrit [102] . The main functional variables describing the convective capacity of the capillaries of the microcirculation to transport oxygen are the tube hematocrit (the hematocrit of the blood in a capillary at a moment in time) and the discharge hematocrit (the hematocrit flowing through the capillaries per unit of time). The diffusive capacity of the microcirculation is described by the FCD (Recommendation #30, Table 9 ). When developing the next generation of automatic analysis software, transparency of algorithms and the ability to measure subsets of microcirculatory variables are of vital importance (Requirement #26 and Recommendation #37, Table 9 ) [103] . When applying such functional analysis software, it will be important to establish normal values in different age populations [24] , and specifically in the developmental stages from the neonates on through childhood (Recommendation #32, Table 9 ) [25] . Following such a description, critical microcirculatory values should be identified, below which pathophysiology is identified (Recommendation #31, Table 9 ).
An additional variable of interest would be to include the hemoglobin saturation of the red blood cells in the field of view in order to complete the description of the oxygen-transporting capacity of the microcirculation. Such measurements have been used in intravital microscopy to investigate oxygen transport in experimental animals [104] . Indeed, such a variable could quite easily be incorporated in HVM by the inclusion of differently colored LEDs [105] . Such a future HVM spectrophotometry method, with the physiological variables proposed, would indeed be a major development in HVM. 35. Tools should be developed to make pressure-artifact-free measurements and allow single-spot measurements to be made during a therapeutic maneuver 36 . Leukocyte tracking and kinetics should be measured and related to activation of inflammatory pathways. Platelet identification is helpful to address the interplay between inflammation and coagulation 37. Technology should be developed to allow stable measurements to be made for longer periods of time to allow continuous measurement during, for example, a therapeutic maneuver allowing observation of the response of single vessels before and after the intervention 38. Optical magnification increases should be possible to identify cellular and subcellular structures (glycocalyx, cell-to-cell connections)
39. It is recommended that trials be undertaken whereby microcirculatory alterations are identified by HVM and corrected by specific interventions that lead to clinically relevant benefit for the patient Consequently, it would allow integration in systemic hemodynamic variables for a comprehensive description of the oxygen-transporting capacity of the cardiovascular system at the bedside. In addition, a more comprehensive measure of heterogeneity could be incorporated which is based on the distribution of flow, thereby allowing a better description of the physiological function of the microcirculation to be accomplished in combination with morphometric analysis. There is also a need for further development of the hardware in order to more readily and reliably perform HVM at the bedside. In this respect, hardware development that allows measurements to be made instantly and without pressure artifacts would greatly facilitate the introduction of HVM into routine use at the bedside. Future developments allowing hands-free measurements to be made, so that measurements can be made in one and the same location for extended periods of time (Recommendation #37, Table 9 ) during therapeutic maneuvers, would allow a much more precise evaluation of the functional state of the microcirculation. Finally, it is conceivable that developments in the optics of HVM systems could allow for much more detailed observations of cellular and even intracellular structures [106] .
The main near-future development for HVM in clinical practice will be its integration with macrohemodynamic measurements, thus providing an integrative and functional evaluation of the cardiovascular system from the heart to the capillaries [107, 108] . In doing so changes in microcirculatory properties in the different phases of life will need to be taken into account alongside the effects of chronic disease states. For the pediatric population longitudinal data are warranted from the "normal" extremely low birth weight infant till adolescence as significant changes have been identified to occur in the first week of life [29] . Furthermore, identifying the presence or absence of hemodynamic coherence between the different compartments of the cardiovascular system may become possible (Recommendation #33, Table 9 ). Although microcirculatory monitoring has improved, training in its use, both in terms of performing the measurements as well as interpreting the images, is necessary. A comprehensive knowledge of the functional behavior of the microcirculation and its cellular components in health and disease will also be essential.
Finally some shortcomings of this consensus need to be mentioned. The use of the Delphi method can be questioned as an appropriate format to reach a consensus and indeed several other methodologies have been put forward to define a consensus [109, 110] . We chose the Delphi method because a previous similar consensus reached from the Cardiovascular Dynamics Section of the ESICM had used the same methodology [54] . In addition, these other methodologies included criteria which were much better suited for more conventional guidelines and devices such as financial considerations, issues we felt were not relevant for our subject matter. A second shortcoming of our consensus is the absence of the availability of more advanced software for analysis of microcirculatory images. Although some initial versions are currently available they require validation and further development by the field.
Conclusion
In this paper we provided a set of guidelines on microcirculatory imaging, using hand-held microscopy at the bedside. We expect that this consensus paper, created by the Cardiovascular Dynamics Section of the ESICM and endorsed by its Executive Committee, will make an important contribution to the current and future use of HVM in critically ill patients.
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